Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 6, 2019British Journal of Biomedical Science

Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals

View Full Paper
Ask AI
Bookmark
Share

Authors

MŁMariusz ŁucejkoKTKrzysztof TomasiewiczAOAnita Olczak

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Łucejko et al. (2019) studied this question.

synapsesocial.com/papers/6ab0cdff97a3794889ec4a6ehttps://doi.org/10.1080/09674845.2019.1654790
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide2006 · 2,597 citations
  2. 2Hepatitis C virus core antigen testing: Role in diagnosis, disease monitoring and treatment2014 · 75 citations